Global Short Bowel Syndrome (SBS) Drugs Market Research Report 2024

Report ID: 1900119 | Published Date: Sep 2024 | No. of Page: 89 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Short Bowel Syndrome (SBS) Drugs Market Overview
    1.1 Product Overview and Scope of Short Bowel Syndrome (SBS) Drugs
    1.2 Short Bowel Syndrome (SBS) Drugs Segment by Type
        1.2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Glucagon-Like Peptide-2 (GLP-2)
        1.2.3 Growth Hormone
        1.2.4 Glutamine
        1.2.5 Other
    1.3 Short Bowel Syndrome (SBS) Drugs Segment by Sale Channel
        1.3.1 Global Short Bowel Syndrome (SBS) Drugs Sales Comparison by Sale Channel: (2022-2028)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Retail Pharmacies
    1.4 Global Short Bowel Syndrome (SBS) Drugs Market Size Estimates and Forecasts
        1.4.1 Global Short Bowel Syndrome (SBS) Drugs Revenue 2017-2028
        1.4.2 Global Short Bowel Syndrome (SBS) Drugs Sales 2017-2028
        1.4.3 Short Bowel Syndrome (SBS) Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Short Bowel Syndrome (SBS) Drugs Market Competition by Manufacturers
    2.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Short Bowel Syndrome (SBS) Drugs Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Short Bowel Syndrome (SBS) Drugs Manufacturing Sites, Area Served, Product Type
    2.5 Short Bowel Syndrome (SBS) Drugs Market Competitive Situation and Trends
        2.5.1 Short Bowel Syndrome (SBS) Drugs Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Short Bowel Syndrome (SBS) Drugs Players Market Share by Revenue
        2.5.3 Global Short Bowel Syndrome (SBS) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Short Bowel Syndrome (SBS) Drugs Retrospective Market Scenario by Region
    3.1 Global Short Bowel Syndrome (SBS) Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Short Bowel Syndrome (SBS) Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
        3.3.1 North America Short Bowel Syndrome (SBS) Drugs Sales by Country
        3.3.2 North America Short Bowel Syndrome (SBS) Drugs Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
        3.4.1 Europe Short Bowel Syndrome (SBS) Drugs Sales by Country
        3.4.2 Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Region
        3.5.1 Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region
        3.5.2 Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
        3.6.1 Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country
        3.6.2 Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Market Facts & Figures by Country
        3.7.1 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country
        3.7.2 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Short Bowel Syndrome (SBS) Drugs Historic Market Analysis by Type
    4.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2017-2022)
    4.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Type (2017-2022)
    4.3 Global Short Bowel Syndrome (SBS) Drugs Price by Type (2017-2022)
5 Global Short Bowel Syndrome (SBS) Drugs Historic Market Analysis by Sale Channel
    5.1 Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2017-2022)
    5.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Sale Channel (2017-2022)
    5.3 Global Short Bowel Syndrome (SBS) Drugs Price by Sale Channel (2017-2022)
6 Key Companies Profiled
    6.1 Merck
        6.1.1 Merck Corporation Information
        6.1.2 Merck Description and Business Overview
        6.1.3 Merck Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Merck Short Bowel Syndrome (SBS) Drugs Product Portfolio
        6.1.5 Merck Recent Developments/Updates
    6.2 Takeda
        6.2.1 Takeda Corporation Information
        6.2.2 Takeda Description and Business Overview
        6.2.3 Takeda Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Takeda Short Bowel Syndrome (SBS) Drugs Product Portfolio
        6.2.5 Takeda Recent Developments/Updates
    6.3 Emmaus Medical
        6.3.1 Emmaus Medical Corporation Information
        6.3.2 Emmaus Medical Description and Business Overview
        6.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product Portfolio
        6.3.5 Emmaus Medical Recent Developments/Updates
    6.4 Ardelyx
        6.4.1 Ardelyx Corporation Information
        6.4.2 Ardelyx Description and Business Overview
        6.4.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Ardelyx Short Bowel Syndrome (SBS) Drugs Product Portfolio
        6.4.5 Ardelyx Recent Developments/Updates
    6.5 Naia Pharmaceuticals
        6.5.1 Naia Pharmaceuticals Corporation Information
        6.5.2 Naia Pharmaceuticals Description and Business Overview
        6.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio
        6.5.5 Naia Pharmaceuticals Recent Developments/Updates
    6.6 Nutrinia
        6.6.1 Nutrinia Corporation Information
        6.6.2 Nutrinia Description and Business Overview
        6.6.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Nutrinia Short Bowel Syndrome (SBS) Drugs Product Portfolio
        6.6.5 Nutrinia Recent Developments/Updates
    6.7 OxThera
        6.6.1 OxThera Corporation Information
        6.6.2 OxThera Description and Business Overview
        6.6.3 OxThera Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 OxThera Short Bowel Syndrome (SBS) Drugs Product Portfolio
        6.7.5 OxThera Recent Developments/Updates
    6.8 Sancilio Pharmaceuticals
        6.8.1 Sancilio Pharmaceuticals Corporation Information
        6.8.2 Sancilio Pharmaceuticals Description and Business Overview
        6.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product Portfolio
        6.8.5 Sancilio Pharmaceuticals Recent Developments/Updates
    6.9 Zealand Pharma
        6.9.1 Zealand Pharma Corporation Information
        6.9.2 Zealand Pharma Description and Business Overview
        6.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product Portfolio
        6.9.5 Zealand Pharma Recent Developments/Updates
7 Short Bowel Syndrome (SBS) Drugs Manufacturing Cost Analysis
    7.1 Short Bowel Syndrome (SBS) Drugs Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Short Bowel Syndrome (SBS) Drugs
    7.4 Short Bowel Syndrome (SBS) Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Short Bowel Syndrome (SBS) Drugs Distributors List
    8.3 Short Bowel Syndrome (SBS) Drugs Customers
9 Short Bowel Syndrome (SBS) Drugs Market Dynamics
    9.1 Short Bowel Syndrome (SBS) Drugs Industry Trends
    9.2 Short Bowel Syndrome (SBS) Drugs Market Drivers
    9.3 Short Bowel Syndrome (SBS) Drugs Market Challenges
    9.4 Short Bowel Syndrome (SBS) Drugs Market Restraints
10 Global Market Forecast
    10.1 Short Bowel Syndrome (SBS) Drugs Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Short Bowel Syndrome (SBS) Drugs by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Short Bowel Syndrome (SBS) Drugs by Type (2023-2028)
    10.2 Short Bowel Syndrome (SBS) Drugs Market Estimates and Projections by Sale Channel
        10.2.1 Global Forecasted Sales of Short Bowel Syndrome (SBS) Drugs by Sale Channel (2023-2028)
        10.2.2 Global Forecasted Revenue of Short Bowel Syndrome (SBS) Drugs by Sale Channel (2023-2028)
    10.3 Short Bowel Syndrome (SBS) Drugs Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Short Bowel Syndrome (SBS) Drugs by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Short Bowel Syndrome (SBS) Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Short Bowel Syndrome (SBS) Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global Short Bowel Syndrome (SBS) Drugs Sales Growth Rate Comparison by Sale Channel (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global Short Bowel Syndrome (SBS) Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Short Bowel Syndrome (SBS) Drugs Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Short Bowel Syndrome (SBS) Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Short Bowel Syndrome (SBS) Drugs Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Short Bowel Syndrome (SBS) Drugs Manufacturing Sites and Area Served
    Table 11. Manufacturers Short Bowel Syndrome (SBS) Drugs Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Short Bowel Syndrome (SBS) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome (SBS) Drugs as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Short Bowel Syndrome (SBS) Drugs Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2017-2022)
    Table 17. Global Short Bowel Syndrome (SBS) Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2017-2022)
    Table 19. North America Short Bowel Syndrome (SBS) Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2017-2022)
    Table 21. North America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2017-2022)
    Table 23. Europe Short Bowel Syndrome (SBS) Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2017-2022)
    Table 25. Europe Short Bowel Syndrome (SBS) Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Short Bowel Syndrome (SBS) Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2017-2022)
    Table 33. Latin America Short Bowel Syndrome (SBS) Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Country (2017-2022)
    Table 39. Global Short Bowel Syndrome (SBS) Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Type (2017-2022)
    Table 41. Global Short Bowel Syndrome (SBS) Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Type (2017-2022)
    Table 43. Global Short Bowel Syndrome (SBS) Drugs Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global Short Bowel Syndrome (SBS) Drugs Sales (K Pcs) by Sale Channel (2017-2022)
    Table 45. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Sale Channel (2017-2022)
    Table 46. Global Short Bowel Syndrome (SBS) Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
    Table 47. Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Sale Channel (2017-2022)
    Table 48. Global Short Bowel Syndrome (SBS) Drugs Price by Sale Channel (2017-2022) & (USD/Pcs)
    Table 49. Merck Corporation Information
    Table 50. Merck Description and Business Overview
    Table 51. Merck Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. Merck Short Bowel Syndrome (SBS) Drugs Product
    Table 53. Merck Recent Developments/Updates
    Table 54. Takeda Corporation Information
    Table 55. Takeda Description and Business Overview
    Table 56. Takeda Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. Takeda Short Bowel Syndrome (SBS) Drugs Product
    Table 58. Takeda Recent Developments/Updates
    Table 59. Emmaus Medical Corporation Information
    Table 60. Emmaus Medical Description and Business Overview
    Table 61. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. Emmaus Medical Short Bowel Syndrome (SBS) Drugs Product
    Table 63. Emmaus Medical Recent Developments/Updates
    Table 64. Ardelyx Corporation Information
    Table 65. Ardelyx Description and Business Overview
    Table 66. Ardelyx Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 67. Ardelyx Short Bowel Syndrome (SBS) Drugs Product
    Table 68. Ardelyx Recent Developments/Updates
    Table 69. Naia Pharmaceuticals Corporation Information
    Table 70. Naia Pharmaceuticals Description and Business Overview
    Table 71. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 72. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product
    Table 73. Naia Pharmaceuticals Recent Developments/Updates
    Table 74. Nutrinia Corporation Information
    Table 75. Nutrinia Description and Business Overview
    Table 76. Nutrinia Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 77. Nutrinia Short Bowel Syndrome (SBS) Drugs Product
    Table 78. Nutrinia Recent Developments/Updates
    Table 79. OxThera Corporation Information
    Table 80. OxThera Description and Business Overview
    Table 81. OxThera Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 82. OxThera Short Bowel Syndrome (SBS) Drugs Product
    Table 83. OxThera Recent Developments/Updates
    Table 84. Sancilio Pharmaceuticals Corporation Information
    Table 85. Sancilio Pharmaceuticals Description and Business Overview
    Table 86. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 87. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Product
    Table 88. Sancilio Pharmaceuticals Recent Developments/Updates
    Table 89. Zealand Pharma Corporation Information
    Table 90. Zealand Pharma Description and Business Overview
    Table 91. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 92. Zealand Pharma Short Bowel Syndrome (SBS) Drugs Product
    Table 93. Zealand Pharma Recent Developments/Updates
    Table 94. Production Base and Market Concentration Rate of Raw Material
    Table 95. Key Suppliers of Raw Materials
    Table 96. Short Bowel Syndrome (SBS) Drugs Distributors List
    Table 97. Short Bowel Syndrome (SBS) Drugs Customers List
    Table 98. Short Bowel Syndrome (SBS) Drugs Market Trends
    Table 99. Short Bowel Syndrome (SBS) Drugs Market Drivers
    Table 100. Short Bowel Syndrome (SBS) Drugs Market Challenges
    Table 101. Short Bowel Syndrome (SBS) Drugs Market Restraints
    Table 102. Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 103. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 104. Global Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 105. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 106. Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Sale Channel (2023-2028) & (K Pcs)
    Table 107. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share Forecast by Sale Channel (2023-2028)
    Table 108. Global Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Sale Channel (2023-2028) & (US$ Million)
    Table 109. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share Forecast by Sale Channel (2023-2028)
    Table 110. Global Short Bowel Syndrome (SBS) Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 111. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share Forecast by Region (2023-2028)
    Table 112. Global Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 113. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Short Bowel Syndrome (SBS) Drugs
    Figure 2. Global Short Bowel Syndrome (SBS) Drugs Market Share by Type in 2021 & 2028
    Figure 3. Glucagon-Like Peptide-2 (GLP-2) Product Picture
    Figure 4. Growth Hormone Product Picture
    Figure 5. Glutamine Product Picture
    Figure 6. Other Product Picture
    Figure 7. Global Short Bowel Syndrome (SBS) Drugs Market Share by Sale Channel in 2021 & 2028
    Figure 8. Hospitals
    Figure 9. Clinics
    Figure 10. Retail Pharmacies
    Figure 11. Global Short Bowel Syndrome (SBS) Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Short Bowel Syndrome (SBS) Drugs Market Size (2017-2028) & (US$ Million)
    Figure 13. Global Short Bowel Syndrome (SBS) Drugs Sales (2017-2028) & (K Pcs)
    Figure 14. Short Bowel Syndrome (SBS) Drugs Sales Share by Manufacturers in 2021
    Figure 15. Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Manufacturers in 2021
    Figure 16. The Global 5 and 10 Largest Short Bowel Syndrome (SBS) Drugs Players: Market Share by Revenue in 2021
    Figure 17. Short Bowel Syndrome (SBS) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region (2017-2022)
    Figure 19. Global Short Bowel Syndrome (SBS) Drugs Sales Market Share by Region in 2021
    Figure 20. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region (2017-2022)
    Figure 21. Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Region in 2021
    Figure 22. U.S. Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Canada Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Germany Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. France Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. U.K. Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Italy Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Russia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. China Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Japan Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. South Korea Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. India Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Australia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. China Taiwan Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Indonesia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Thailand Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Malaysia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Mexico Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Brazil Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Argentina Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Turkey Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Saudi Arabia Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. UAE Short Bowel Syndrome (SBS) Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Sales Market Share of Short Bowel Syndrome (SBS) Drugs by Type (2017-2022)
    Figure 45. Manufacturing Cost Structure of Short Bowel Syndrome (SBS) Drugs
    Figure 46. Manufacturing Process Analysis of Short Bowel Syndrome (SBS) Drugs
    Figure 47. Short Bowel Syndrome (SBS) Drugs Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma
Frequently Asked Questions
Short Bowel Syndrome (SBS) Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Short Bowel Syndrome (SBS) Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Short Bowel Syndrome (SBS) Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports